Top news of May: Alcohol consumption, isotretinoin, antihypertensive medications, more
Click Here to Manage Email Alerts
Healio has compiled May’s most-read news in dermatology.
A feature on the effects of alcohol consumption on the skin dominated headlines followed by new studies on the laboratory monitoring guidelines for isotretinoin, the association between antihypertensive medications and eczematous dermatitis and the power of antioxidant-rich diets for women with acne.
Q&A: Alcohol consumption can age skin, trigger underlying diseases
Many are unaware that not only does consuming alcohol negatively affect the skin, but doing so in the heat can cause even more damage. Ahuva Cices, MD, assistant professor of the Kimberly and Eric J. Waldman Department of Dermatology at Icahn School of Medicine at Mount Sinai, shared her insights. Read more.
To test or not to test: Isotretinoin marginally increases risk for severe adverse events
Researchers found that isotretinoin is associated with a clinically marginal increased risk for severe adverse events and suggested that laboratory testing guidelines should be relaxed. Also, John Barbieri, MD, MBA, assistant professor of dermatology at Harvard Medical School, director of the Advanced Acne Therapeutics Clinic at Brigham and Women’s Hospital and co-chair of the AAD Acne Guidelines Work Group, gave his Perspective. Read more.
Antihypertensive medications associated with eczematous dermatitis in older patients
Due to a small increase in eczematous dermatitis, older adults taking antihypertensive drugs should be monitored and this possibility considered when assessing for eczema, according to a study. Read more.
Antioxidant-rich diets may improve quality of life in women with acne
Published in Nutrients, a study found that a high adherence to an antioxidant diet reduced the risk for acne and positively impacts quality of life, including depression levels, in women. Read more.
‘Anxiety about aging’: How dermatologists can discuss sun safety with Gen Z adults
According to a recent survey conducted by the American Academy of Dermatology, Generation Z adults, also known as Gen Z, are obsessed with skin care but are less enthusiastic about sunscreen. They are also terrified of aging, making this finding extremely paradoxical. Heather D. Rogers, MD, FAAD, a dermatologist in Seattle, shared her expertise on this topic. Read more.
OTC healing ointment improves dry skin, surgical wounds
A study found that Cetaphil Healing ointment (Galderma Laboratories), an over-the-counter topical that contains petrolatum, shea butter and vitamin E, was safe and effective for treating dry, itchy skin and surgical sounds from dermatologic procedures. Read more.
Stress may be associated with increased risk for psoriasis among men
Healio soke with Marta Laskowski, MD, PhD, of the department of dermatology and venereology at the University of Gothenburg and Sahlgrenska University Hospital, about her study which found that low stress resilience in men may be linked to an increased risk for developing psoriasis or psoriatic arthritis. Joel M. Gelfand, MD, MSCE, James J. Leyden professor of clinical investigation and dermatology at the University of Pennsylvania’s Perelman School of Medicine and Healio Dermatology’s Chief Medical Editor, contributed his Perspective. Read more.
Simlandi launches in US as third interchangeable Humira biosimilar
On May 20, Teva Pharmaceuticals and Alvotech officially launched Simlandi (adalimumab-ryvk) injection in the U.S., making it the third interchangeable Humira biosimilar for the treatment of psoriatic arthritis and plaque psoriasis. Read more.
Mohs surgery techniques may cause hyperpigmentation among patients with skin of color
Specific procedural factors were proven to influence post-inflammatory hyperpigmentation following Mohs micrographic surgery among patients with skin of color. Read more.
Beneath the Surface: Addressing JAK inhibitor safety in alopecia with Brett King, MD, PhD
In this edition of Healio Dermatology’s Beneath the Surface video series, Gelfand discussed the safety of Janus kinase inhibitors for the treatment of alopecia areata with Brett King, MD, PhD, associate professor of dermatology at Yale University School of Medicine and a member of Healio Dermatology’s Peer Perspective Board. Read more.
Collapse
Healio Coverage
Read more about
Click Here to Manage Email Alerts